Medtecs International Corporation Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 56.88 million compared to USD 144.16 million a year ago. Net loss was USD 28.53 million compared to net income of USD 17.34 million a year ago.

Basic loss per share from continuing operations was USD 0.05232 compared to basic earnings per share from continuing operations of USD 0.03171 a year ago. Diluted loss per share from continuing operations was USD 0.05232 compared to diluted earnings per share from continuing operations of USD 0.03171 a year ago.